脑硬膜动脉血管融通术治疗出血性烟雾病:单中心95例连续成人患者的长期结局
该研究回顾性分析了95例在307医院接受脑硬膜动脉血管融通术(EDAS)治疗的出血性烟雾病成人患者,中位随访8.5年,16例(16.8%)发生再出血,年再出血率为每人每年2.2%。症状起始年龄是再出血的预测因素(OR 1.075,95%CI 1.008-1.147,p=0.028),后循环出血组再出血率高于前循环组但差异无统计学意义(p>0.05)。
要点
- 95例出血性烟雾病成人患者EDAS后中位随访8.5年,16例(16.8%)再出血,年再出血率2.2%/人年。
- 症状起始年龄是再出血预测因素(OR 1.075,95%CI 1.008-1.147,p=0.028)。
- 后循环出血组再出血率高于前循环组,但差异无统计学意义(p>0.05)。
核心结论
- 长期随访显示EDAS对出血性烟雾病患者有益;AChA-PCoA扩张与烟雾病初始出血相关,再出血与年龄相关;出血性烟雾病患者即使神经状态良好也应终身随访。
研究设计与样本
- 回顾性研究,纳入在307医院接受EDAS治疗的95例出血性烟雾病成人患者,分析临床特征、血管造影表现和临床结局。
主要发现
- 成人患者症状起始平均年龄37.1岁(范围20-54岁),女性与男性比例为1.16:1。
- 95个出血半球中61个(64.2%)AChA或PCoA极度扩张并超出脉络裂,非出血半球86个中仅28个(32.6%)出现此表现。
- 57次出血归类为前循环出血,38次为后循环出血。
- 95例患者中16例(16.8%)在中位随访8.5年后发生脑再出血,年再出血率为每人每年2.2%。
- 后循环组再出血发生率高于前循环组,但差异无统计学意义(p>0.05);Cox回归显示症状起始年龄是再出血卒中的预测因素(OR 1.075,95%CI 1.008-1.147,p=0.028)。
临床怎么用
- 作者认为EDAS对出血性烟雾病患者有益,并建议出血性烟雾病患者即使神经状态良好也应终身随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to investigate long-term outcomes after encephaloduroarteriosynangiosis (EDAS) for the treatment of hemorrhagic moyamoya disease (MMD) and identify the risk factors for recurrent hemorrhages. METHODS: The authors retrospectively reviewed 95 patients with hemorrhagic MMD who were treated with EDAS at 307th Hospital PLA. Clinical features, angiographic findings, and clinical outcomes were investigated. Rebleeding incidences were compared between anterior or posterior hemorrhagic sites. Kaplan-Meier survival analysis and Cox proportional hazards regression models were used to estimate rebleeding risks after EDAS. RESULTS: The average age at symptom onset was 37.1 years (range 20-54 years) for adult patients. The ratio of female to male patients was 1.16:1. In 61 of 95 hemorrhagic hemispheres (64.2%), the anterior choroidal artery (AChA) or posterior communicating artery (PCoA) was extremely dilated, with extensive branches beyond the choroidal fissure, which only occurred in 28 of 86 nonhemorrhagic hemispheres (32.6%). Fifty-seven incidences were classified as anterior hemorrhages and 38 as posterior. Sixteen of 95 patients (16.8%) suffered cerebral rebleeding after a median follow-up duration of 8.5 years. The annual rebleeding rate was 2.2% per person per year. The incidence rate was higher for the posterior group than for the anterior group, but this difference was not statistically significant (p > 0.05). Cox regression analysis revealed that the age of symptom onset (OR 1.075, 95% CI 1.008-1.147, p = 0.028) was a predictor of rebleeding strokes. CONCLUSIONS: Through long-term follow up, EDAS proved beneficial for patients with hemorrhagic MMD. Dilation of the AChA-PCoA is associated with the initial hemorrhage of MMD, and rebleeding is age-related. Patients with hemorrhagic MMD should undergo follow-up over the course of their lives, even when neurological status is excellent.
引用
- Wang QN, Bao XY, Zhang Y, et al. Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center. J Neurosurg. 2018. PMID: 29999465. doi:10.3171/2017.12.JNS172246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。